Hayashi S, Watanabe N, Nakazawa K, Suzuki J, Tsushima K, Tamatani T, Sakamoto S, Isobe M
First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Circulation. 2000 Oct 3;102(14):1710-7. doi: 10.1161/01.cir.102.14.1710.
P-selectin plays key roles in mediating inflammation through promoting adherence of leukocytes to activated platelets and endothelium. This process is one of the initial events in atherosclerosis and restenosis after coronary angioplasty.
Using a rat balloon-injury model, we examined the role of P-selectin in vascular inflammatory processes. In the acute phase, immunohistochemistry revealed that P-selectin was intensely expressed on both activated platelets covering the denuded segment and endothelial cells of the inflamed adventitial small vessels. Treatment with an anti-P-selectin monoclonal antibody (MAb) for 8 consecutive days significantly inhibited neointimal formation at day 14 (42% inhibition; P:<0.05), and this effect persisted at day 56 (40% inhibition; P:<0.01) compared with the control group. Vascular shrinking accompanying adventitial fibrosis was also attenuated at day 56. Inhibition of both neointimal formation and vascular shrinking resulted in the lumen area of the anti-P-selectin treatment group being approximately 3 times larger at day 56 than that of the control group. Accumulation of CD45-positive leukocytes in the developing neointima, media, and adventitia at day 8 was significantly inhibited by treatment with the anti-P-selectin MAb. Scanning electron microscopy demonstrated that anti-P-selectin treatment resulted in a less thrombogenic surface of the arterial intima, which featured a pseudoendothelial appearance at day 14 after injury.
These results suggest that inhibition of P-selectin-mediated leukocyte recruitment prevents the development of neointimal formation, adventitial inflammation, and vascular shrinking and promotes pseudoendothelialization by luminal smooth muscle cells. This treatment thus beneficially affects vascular remodeling after balloon injury in rats.
P-选择素通过促进白细胞与活化血小板及内皮细胞的黏附在介导炎症过程中发挥关键作用。这一过程是动脉粥样硬化和冠状动脉成形术后再狭窄的初始事件之一。
利用大鼠球囊损伤模型,我们研究了P-选择素在血管炎症过程中的作用。在急性期,免疫组织化学显示,P-选择素在覆盖剥脱段的活化血小板以及炎症外膜小血管的内皮细胞上均有强烈表达。连续8天用抗P-选择素单克隆抗体(MAb)治疗,与对照组相比,在第14天显著抑制了新生内膜形成(抑制率42%;P<0.05),且在第56天这种作用持续存在(抑制率40%;P<0.01)。在第56天,伴随外膜纤维化的血管收缩也有所减轻。新生内膜形成和血管收缩的抑制导致抗P-选择素治疗组在第56天的管腔面积比对照组大约大3倍。抗P-选择素MAb治疗显著抑制了第8天新生内膜、中膜和外膜中CD45阳性白细胞的积聚。扫描电子显微镜显示,抗P-选择素治疗使动脉内膜的血栓形成表面减少,在损伤后第14天呈现假内皮外观。
这些结果表明,抑制P-选择素介导的白细胞募集可防止新生内膜形成、外膜炎症和血管收缩的发展,并促进管腔平滑肌细胞的假内皮化。因此,这种治疗对大鼠球囊损伤后的血管重塑有有益影响。